@article{73efc2e84e8c430bbf9e17ede29d34f5,
title = "Response to rituximab-based therapy and risk factor analysis in epstein barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation",
abstract = " The objective of this analysis was to investigate prognostic factors that influence the outcome of Epstein-Barr virus (EBV)-related posttransplant lymphoproliferative disorder (PTLD) after a rituximab-based treatment in the allogeneic hematopoietic stem cell transplant (HSCT) setting.",
keywords = "Epstein-Barr virus, hematopoietic stem cell transplantation, post-transplant lymphoproliferative disorder, prognostic model, risk factors, Epstein-Barr virus, hematopoietic stem cell transplantation, post-transplant lymphoproliferative disorder, prognostic model, risk factors",
author = "Jan Styczynski and Lidia Gil and Gloria Tridello and Per Ljungman and Donnelly, {J. Peter} and {Van Der Velden}, Walter and Hamdy Omar and Rodrigo Martino and Constantijn Halkes and Maura Faraci and Koen Theunissen and Krzysztof Kalwak and Petr Hubacek and Simona Sica and Chiara Nozzoli and Franca Fagioli and Susanne Matthes and Diaz, {Miguel A.} and Maddalena Migliavacca and Adriana Balduzzi and Agnieszka Tomaszewska and Camara, {Rafael De La} and {Van Biezen}, Anja and Jennifer Hoek and Simona Iacobelli and Hermann Einsele and Simone Cesaro",
year = "2013",
doi = "10.1093/cid/cit391",
language = "English",
volume = "57",
pages = "794--802",
journal = "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
}